Pharmacotherapy for obstructive sleep apnea: targeting specific pathophysiological traits

E Perger, S Bertoli, C Lombardi - Expert Review of Respiratory …, 2023 - Taylor & Francis
Introduction The pathophysiology of obstructive sleep apnea (OSA) is multi-factorial and
complex. Varying OSA's pathophysiological traits have been identified, including pharyngeal …

[HTML][HTML] A scoping review of sleep apnea: where do we stand?

R Hirani, A Smiley - Life, 2023 - mdpi.com
Obstructive sleep apnea (OSA), a condition in which there is a recurrent collapse of the
upper airway while sleeping, is a widespread disease affecting 5% to 10% people …

[HTML][HTML] Impact of reboxetine plus oxybutynin treatment for obstructive sleep apnea on cardiovascular autonomic modulation

E Perger, P Castiglioni, A Faini, D Soranna… - Scientific Reports, 2023 - nature.com
The combination of noradrenergic (reboxetine) plus antimuscarinic (oxybutynin) drugs (reb-
oxy) reduced obstructive sleep apnea (OSA) severity but no data are available on its effects …

[HTML][HTML] Obstructive sleep apnea and adherence to continuous positive airway pressure (CPAP) treatment: let's talk about partners!

D Rosa, C Amigoni, E Rimoldi, P Ripa, A Ligorio… - Healthcare, 2022 - mdpi.com
Background: Continuous positive airway pressure (CPAP) is the gold standard treatment for
obstructive sleep apnea (OSA). The benefits of this therapy were studied and analyzed over …

[HTML][HTML] Adherence to CPAP treatment: can mindfulness play a role?

A Pataka, SC Kotoulas, PR Gavrilis, A Karkala… - Life, 2023 - mdpi.com
Obstructive sleep apnea (OSA) is considered a chronic disease that requires long-term
multidisciplinary management for effective treatment. Continuous Positive Airway Pressure …

Sleep and epilepsy: practical implications

MM Grigg-Damberger… - Neurologic …, 2022 - neurologic.theclinics.com
Sleep and Epilepsy - Neurologic Clinics Skip to Main Content Advertisement Neurologic
Clinics Log in Register Log in Subscribe Claim Skip menu theclinics.com theclinics.com …

BTS Clinical Statement on the prevention and management of community-acquired pneumonia in people with learning disability

J Legg, JL Allen, M Andrew, C Annesley, M Chatwin… - Thorax, 2023 - thorax.bmj.com
This BTS Clinical Statement addresses the risk assessment, prevention and management of
community-acquired pneumonia (CAP) in people with a learning disability of all ages. Each …

Motivational interviewing effects on positive airway pressure therapy (PAP) adherence: A systematic review and meta-analysis of randomized controlled trials

ES Crosby, EG Spitzer, J Kavookjian - Behavioral Sleep Medicine, 2023 - Taylor & Francis
Objectives This systematic review and meta-analysis examined Motivational Interviewing
(MI) effects on positive airway pressure (PAP) adherence and related outcomes. Method …

[HTML][HTML] Assessing the needs and perspectives of patients with obesity and obstructive sleep apnea syndrome following continuous positive airway pressure therapy …

G Rapelli, G Pietrabissa, L Angeli, I Bastoni… - Frontiers in …, 2022 - frontiersin.org
Objective This study aims to investigate the lived experience in patients with obstructive
sleep apnea syndrome (OSAS) and comorbid obesity following after continuous positive …

Effectiveness of behavioral and psychosocial interventions for continuous positive airway pressure adherence among patients with obstructive sleep apnea: A …

J Chaiard, P Bhatarasakoon - Applied Nursing Research, 2023 - Elsevier
Background Continuous positive airway pressure (CPAP) therapy is the treatment of choice
for Obstructive Sleep Apnea (OSA) syndrome; however, interventions to improve CPAP …